Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Moderna, Inc. - Common Stock (NQ:MRNA)

23.65 -0.37 (-1.54%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 14,890,174
Open 24.30
Bid (Size) 23.55 (1)
Ask (Size) 23.62 (73)
Prev. Close 24.02
Today's Range 23.16 - 24.31
52wk Range 23.15 - 170.47
Shares Outstanding 387,000,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
MRNA Q1 Earnings Call: Management Focuses on Cost Reductions and Pipeline Progress Amid Revenue Shortfall
Biotechnology company Moderna (NASDAQ:MRNA) missed Wall Street’s revenue expectations in Q1 CY2025, with sales falling 35.3% year on year to $108 million. The company’s full-year revenue guidance of $2... 
Via StockStory
Exposures COVID-19
Stay informed with the top movers within the S&P500 index on Wednesday.
Join us in exploring the top gainers and losers within the S&P500 index one hour before the close of the markets on Wednesday as we examine the latest happenings in today's session. 
Via Chartmill

Performance

YTD
-43.7%
-43.7%
1 Month
-9.9%
-9.9%
3 Month
-25.9%
-25.9%
6 Month
-40.5%
-40.5%
1 Year
-81.7%
-81.7%

More News

Read More
What's going on in today's session: S&P500 movers
Via Chartmill
Earnings Scheduled For May 1, 2025
Via Benzinga
Preview: Moderna's Earnings
Via Benzinga
Thermo Fisher, Biogen, Gilead Sciences, Moderna, and QuidelOrtho Stocks Trade Up, What You Need To Know
Via StockStory
Topics Government Stocks World Trade
Exposures Political Tariff US Equities
Moderna to Present at Upcoming Bernstein's 41st Annual Strategic Decisions Conference (SDC) on May 29, 2025
Via ACCESS Newswire
Top gainers and losers in the S&P500 index during Wednesday's after-hours session.
Via Chartmill
Vinay Prasad's Appointment To FDA's CBER Triggers Questions Over Future Of Cell And Gene Therapy Regulation
Via Benzinga
Exposures Product Safety
Market Monitor May 7 ( Hims & Hers Health, Upwork UP - Palantir, Monderna DOWN)
Via Chartmill
What's going on in today's session: S&P500 movers
Via Chartmill
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Which S&P500 stocks are gapping on Tuesday?
Via Chartmill
Vertex Pharmaceuticals Topples 12% On A Series Of First-Quarter Setbacks
Via Investor's Business Daily
Topics Government Intellectual Property
Exposures Intellectual Property Political
3 Cash-Heavy Stocks in the Doghouse
Via StockStory
Topics Economy
Exposures COVID-19 Supply Chain
What's going on in today's session: S&P500 movers
Via Chartmill
Moderna Expands Cost-Cutting Program By Up To $1.7 Billion, FDA Approval For Flu/COVID-19 Combo Shot Delayed Into 2026
Via Benzinga
Exposures Product Safety
Thursday's session: gap up and gap down stock in the S&P500 index
Via Chartmill
Moderna Reports Q1 Revenue Drop, Warns Of Delay In Covid/Flu Vaccine Approval: Retail Sentiment Sours
Via Stocktwits
Exposures COVID-19
These S&P500 stocks are moving in today's pre-market session
Via Chartmill
Moderna (NASDAQ:MRNA) Misses Q1 Revenue Estimates
Via StockStory
Exposures COVID-19
Moderna Misses Sales Forecasts, But Maintains Full-Year Outlook
Via Investor's Business Daily
Topics Earnings Government
Exposures COVID-19 Financial Political
Moderna Reports First Quarter 2025 Financial Results and Provides Business Updates
Via ACCESS Newswire
Moderna (MRNA) Reports Earnings Tomorrow: What To Expect
Via StockStory
Topics Artificial Intelligence World Trade
Exposures Artificial Intelligence Tariff
Trump-Era FDA Appointees Request New Trials For Novavax COVID Vaccine, Reportedly Delaying Approval Timeline
Via Benzinga
Topics Government
Exposures COVID-19 Political Product Safety

Frequently Asked Questions

Is Moderna, Inc. - Common Stock publicly traded?
Yes, Moderna, Inc. - Common Stock is publicly traded.
What exchange does Moderna, Inc. - Common Stock trade on?
Moderna, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Moderna, Inc. - Common Stock?
The ticker symbol for Moderna, Inc. - Common Stock is MRNA on the Nasdaq Stock Market
What is the current price of Moderna, Inc. - Common Stock?
The current price of Moderna, Inc. - Common Stock is 23.65
When was Moderna, Inc. - Common Stock last traded?
The last trade of Moderna, Inc. - Common Stock was at 05/15/25 04:00 PM ET
What is the market capitalization of Moderna, Inc. - Common Stock?
The market capitalization of Moderna, Inc. - Common Stock is 9.15B
How many shares of Moderna, Inc. - Common Stock are outstanding?
Moderna, Inc. - Common Stock has 9B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.